Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: ACLID, INC.
Awarding agency: Department of Defense / Defense Threat Reduction Agency
Funding agency: Department of Defense / Defense Threat Reduction Agency
Period of performance: 2024-10-21 to 2025-05-20
Current total value of award: $167338.22
Description: SIBR PHASE I - ACLID NUCLEOTIDE SEQUENCING RESEARCH AND DEVELOPMENT STUDY